GLP-1 drugs: benefits and rebound weight

A.M. Edition for Jan. 29. Investors are rewarding Meta after the company’s latest earnings showed massive AI investments translating into a jump in digital-ad revenues. State Street’s Altaf Kassam gives his take on the AI boom’s early winners and losers. Plus, WSJ deputy finance editor Quentin Webb gives us the backstory on the metals rally that just won’t quit. And FBI agents search a Georgia election office as part of a broader push to re-examine Trump’s 2020 loss. Luke Vargas hosts.

Check out Sumathi Reddy's reporting on what happens when you stop taking GLP-1 drugs.

Sign up for the WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices